Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 40 studies | 33% ± 14% | |
endothelial cell of artery | 15 studies | 53% ± 18% | |
endothelial cell of lymphatic vessel | 12 studies | 28% ± 8% | |
capillary endothelial cell | 12 studies | 28% ± 5% | |
endothelial cell of vascular tree | 11 studies | 25% ± 15% | |
vein endothelial cell | 7 studies | 25% ± 11% | |
epithelial cell | 7 studies | 27% ± 8% | |
fibroblast | 5 studies | 23% ± 8% | |
glomerular endothelial cell | 4 studies | 40% ± 4% | |
astrocyte | 4 studies | 22% ± 4% | |
goblet cell | 4 studies | 28% ± 18% | |
mesothelial cell | 3 studies | 30% ± 12% | |
GABAergic neuron | 3 studies | 28% ± 7% | |
glutamatergic neuron | 3 studies | 42% ± 18% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 3667.98 | 966 / 966 | 99% | 40.90 | 524 / 527 |
prostate | 100% | 3011.71 | 245 / 245 | 99% | 34.65 | 498 / 502 |
esophagus | 100% | 2110.87 | 1444 / 1445 | 98% | 41.12 | 180 / 183 |
stomach | 99% | 2066.72 | 356 / 359 | 99% | 36.01 | 283 / 286 |
thymus | 100% | 2910.40 | 652 / 653 | 96% | 19.80 | 582 / 605 |
lung | 100% | 5392.25 | 578 / 578 | 93% | 21.31 | 1072 / 1155 |
bladder | 100% | 1478.62 | 21 / 21 | 92% | 25.67 | 465 / 504 |
uterus | 100% | 2293.76 | 170 / 170 | 89% | 20.65 | 408 / 459 |
breast | 100% | 3978.70 | 459 / 459 | 88% | 14.39 | 985 / 1118 |
kidney | 100% | 2152.39 | 89 / 89 | 87% | 26.62 | 780 / 901 |
ovary | 79% | 1519.09 | 142 / 180 | 95% | 26.94 | 407 / 430 |
adrenal gland | 97% | 1283.12 | 251 / 258 | 71% | 10.58 | 164 / 230 |
brain | 97% | 1777.13 | 2575 / 2642 | 67% | 10.31 | 474 / 705 |
pancreas | 45% | 345.77 | 148 / 328 | 98% | 33.54 | 174 / 178 |
skin | 94% | 2908.35 | 1698 / 1809 | 36% | 5.42 | 169 / 472 |
adipose | 100% | 4182.33 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1675.35 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2461.07 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1728.59 | 849 / 861 | 0% | 0 | 0 / 0 |
liver | 49% | 438.98 | 110 / 226 | 40% | 3.85 | 163 / 406 |
muscle | 88% | 776.32 | 706 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 14.61 | 38 / 45 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.87 | 7 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.07 | 1 / 80 |
peripheral blood | 1% | 4.01 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034332 | Biological process | adherens junction organization |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0009887 | Biological process | animal organ morphogenesis |
GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
GO_0031295 | Biological process | T cell costimulation |
GO_2000727 | Biological process | positive regulation of cardiac muscle cell differentiation |
GO_0007155 | Biological process | cell adhesion |
GO_0099072 | Biological process | regulation of postsynaptic membrane neurotransmitter receptor levels |
GO_0007267 | Biological process | cell-cell signaling |
GO_0010839 | Biological process | negative regulation of keratinocyte proliferation |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_1903849 | Biological process | positive regulation of aorta morphogenesis |
GO_0050920 | Biological process | regulation of chemotaxis |
GO_0099149 | Biological process | regulation of postsynaptic neurotransmitter receptor internalization |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0072178 | Biological process | nephric duct morphogenesis |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0048514 | Biological process | blood vessel morphogenesis |
GO_0001945 | Biological process | lymph vessel development |
GO_0048845 | Biological process | venous blood vessel morphogenesis |
GO_0043616 | Biological process | keratinocyte proliferation |
GO_0007411 | Biological process | axon guidance |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0098685 | Cellular component | Schaffer collateral - CA1 synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0042734 | Cellular component | presynaptic membrane |
GO_0005925 | Cellular component | focal adhesion |
GO_0005912 | Cellular component | adherens junction |
GO_0046875 | Molecular function | ephrin receptor binding |
GO_0001618 | Molecular function | virus receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | EFNB2 |
Protein name | Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L) Ephrin-B2 |
Synonyms | HTKL LERK5 EPLG5 |
Description | FUNCTION: Cell surface transmembrane ligand for Eph receptors, a family of receptor tyrosine kinases which are crucial for migration, repulsion and adhesion during neuronal, vascular and epithelial development. Binds promiscuously Eph receptors residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. Binds to receptor tyrosine kinase including EPHA4, EPHA3 and EPHB4. Together with EPHB4 plays a central role in heart morphogenesis and angiogenesis through regulation of cell adhesion and cell migration. EPHB4-mediated forward signaling controls cellular repulsion and segregation from EFNB2-expressing cells. May play a role in constraining the orientation of longitudinally projecting axons. .; FUNCTION: (Microbial infection) Acts as a receptor for Hendra virus and Nipah virus. . |
Accessions | P52799 Q2PDH7 ENST00000646441.1 |